Hypoglossal nerve stimulation for treatment of obstructive sleep apnea (OSA): a primer for oral and maxillofacial surgeons.
Sung Ok HongYu-Feng ChenJunho JungYong-Dae KwonStanley Yung Chuan LiuPublished in: Maxillofacial plastic and reconstructive surgery (2017)
The prevalence of obstructive sleep apnea (OSA) is estimated to be 1-5% of the adult population world-wide, and in Korea, it is reported at 4.5% of men and 3.2% of women (Age 40 to 69 years old). Active treatment of OSA is associated with decrease in insulin resistance, cardiovascular disease, psychosocial problems, and mortality. Surgical treatment of OSA has evolved in the era of neuromodulation with the advent of hypoglossal nerve stimulation (HGNS). We share this review of HGNS with our maxillofacial surgical colleagues to expand the scope of surgical care for OSA.
Keyphrases
- obstructive sleep apnea
- positive airway pressure
- cardiovascular disease
- sleep apnea
- insulin resistance
- mental health
- healthcare
- polycystic ovary syndrome
- type diabetes
- risk factors
- cardiovascular events
- quality improvement
- adipose tissue
- metabolic syndrome
- pregnant women
- high fat diet
- combination therapy
- coronary artery disease
- pain management
- weight loss
- chronic pain
- smoking cessation
- thoracic surgery